Editorial - (2020) Volume 11, Issue 4
Received: 01-Jul-2020
Published:
30-Jul-2020
Citation: Pardo OE. "2020 Market Analysis on Cancer Therapy & Radiation Oncology". J Nucl Med Radiat Ther 11 (2020) doi: 2155-9619.11.4
Copyright: © 2020 Pardo OE. This is an open access article distributed under the terms of the creative commons attribution license which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
The recent advancements in the cancer treatments & cancer care are accelerating. A cluster of innovative treatments, often combined with other new or existing medicines, and frequently associated with biomarkers, are emerging from the research and development pipeline.
Over the past five years, 70 new oncology treatments have been launched and are being used to treat over 20 different tumor types.
The global cancer biomarker market size was valued at USD 10.3 billion in the year 2016 and is estimated to reach a value of USD 33.7 billion by 2025, growing with CAGR of 14.3 %. Growing prevalence of malignancies coupled with increasing focus on development of targeted therapies is a major factor affirming growth of this market.
Global cancer drugs market accounted for $78,238.9 million in 2015. The cancer drugs market is driven by the growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, continuous patent expiry of key cancer drugs and the rising impact of biosimilar. Global Oncology/Cancer Drugs Market is expected to garner $111.9 billion by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumor cell specific genes.
The global cancer diagnostics market is segmented based on technology, application, and region. This report studies the global cancer diagnostics market for the forecast period of 2015 to 2020. This market is expected to reach $13.1 Billion by 2020 from $7.1 Billion in 2015, and is poised to grow at a CAGR of 12.9% during the forecast period.
Importance and Scope
Radiation therapy is one of the prominent therapies used today in the treatment of cancer. Developed countries such as U.S., Europe have already considered radiotherapy procedure as the gold standard for cancer treatment. Radiotherapy refers to therapeutic procedures using high-energy electromagnetic waves or radioactive particulates to thwart abnormal cell growths and repair different physiological abnormalities within the human body. Euro Cancer 2020 will be the best platform for radiologists, oncologists, researchers working in this field to connect and exchange ideas.
Target Audience
1. Oncologists
2. Radiologists
3. Chemotherapists
4. Doctors
5. Oncology Institutes
6. Medical Colleges
7. Research faculty
8. Academic Scientists
9. Students
10. Cancer Diagnostics Associations and Societies
11. Diagnostic laboratory professionals
12. Business Entrepreneurs
13. Industry professionals
14. Directors/Managers/CEO’s
Related Companies/Industries
1. Roche
2. Celgene Corporation
3. Johnson & Johnson
4. Pfizer Inc.
5. Bristol-Myers Squibb
6. Galenicum
7. Merck & Co., Inc.
8. AstraZeneca
9. AbbVie
10. Eli Lilly
11. Pangaea Oncology
12. Enia Lipotech
13. Ability Pharma
Related Associations and Societies:
1. Society of Oncology and Cancer Research of Nigeria (SOCRON)
2. European society for medical oncology
3. American Society of Clinical Oncology
4. Swiss Group for Clinical Cancer Research
5. American Institute for Cancer Research (AICR)
6. National Foundation for Cancer Research
7. Cancer Research Institute
8. Institute of Cancer Research, London
9. European Academy of Tumour Immunology (EATI)
10. American Association for Cancer Research (AACR)
11. National Cancer Institute
12. Cancer Research UK
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report
